Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One-to-one Service for Combined Injectable Contraceptive Continuation
NCT05362019Unknown
- Sponsor
- National Research Institute for Family Planning
- Start
- May 2022
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by National Research Institute for Family Planning. Primary endpoints: Termination rate at 6 months, Continuation rate at 6 months and 1 more. Status: unknown.
Beyond the preview
Go deeper on NCT05362019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05362019.